Westfield Capital Management CO LP Rocket Pharmaceuticals, Inc. Transaction History
Westfield Capital Management CO LP
- $18.7 Billion
- Q1 2024
A detailed history of Westfield Capital Management CO LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 3,984,030 shares of RCKT stock, worth $84.9 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
3,984,030
Previous 3,941,859
1.07%
Holding current value
$84.9 Million
Previous $118 Million
9.15%
% of portfolio
0.57%
Previous 0.69%
Shares
22 transactions
Others Institutions Holding RCKT
# of Institutions
206Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$377 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$195 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$89.4 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.61B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...